Houfang Long

1.1k total citations
11 papers, 541 citations indexed

About

Houfang Long is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Houfang Long has authored 11 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 5 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Houfang Long's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Alzheimer's disease research and treatments (5 papers) and Neurological disorders and treatments (4 papers). Houfang Long is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Alzheimer's disease research and treatments (5 papers) and Neurological disorders and treatments (4 papers). Houfang Long collaborates with scholars based in China, Thailand and Germany. Houfang Long's co-authors include Cong Liu, Dan Li, Zhenying Liu, Yunpeng Sun, Chunyu Zhao, Kun Zhao, Youqi Tao, Yilun Tong, Shengnan Zhang and Yeh‐Jun Lim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The FASEB Journal.

In The Last Decade

Houfang Long

10 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Houfang Long China 7 270 247 234 84 69 11 541
Timo Strohäker Germany 11 269 1.0× 221 0.9× 190 0.8× 84 1.0× 57 0.8× 13 488
Diana Arseni United Kingdom 6 205 0.8× 394 1.6× 342 1.5× 62 0.7× 89 1.3× 7 648
Srdja Drakulić Denmark 8 212 0.8× 219 0.9× 244 1.0× 59 0.7× 35 0.5× 13 490
Wencheng Xia China 14 202 0.7× 369 1.5× 199 0.9× 52 0.6× 39 0.6× 26 624
Youqi Tao China 14 285 1.1× 304 1.2× 282 1.2× 78 0.9× 54 0.8× 25 671
Yuriy Sharikov United States 8 278 1.0× 161 0.7× 203 0.9× 107 1.3× 48 0.7× 12 503
Rachel L. Redler United States 10 343 1.3× 291 1.2× 139 0.6× 48 0.6× 67 1.0× 15 612
Pratibha Kumari Switzerland 7 333 1.2× 232 0.9× 283 1.2× 86 1.0× 59 0.9× 7 565
Shahin Zibaee United Kingdom 8 353 1.3× 237 1.0× 272 1.2× 120 1.4× 82 1.2× 9 590

Countries citing papers authored by Houfang Long

Since Specialization
Citations

This map shows the geographic impact of Houfang Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houfang Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houfang Long more than expected).

Fields of papers citing papers by Houfang Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Houfang Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houfang Long. The network helps show where Houfang Long may publish in the future.

Co-authorship network of co-authors of Houfang Long

This figure shows the co-authorship network connecting the top 25 collaborators of Houfang Long. A scholar is included among the top collaborators of Houfang Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Houfang Long. Houfang Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Xiong, Xingyu, Houfang Long, Y. H. Yu, et al.. (2025). Design of Ig-like binders targeting α-synuclein fibril for mitigating its pathological activities. Nature Communications. 16(1). 7368–7368.
2.
Liu, Yan, Rui Guo, Houfang Long, et al.. (2025). Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination. Nature Communications. 16(1). 1438–1438. 4 indexed citations
3.
Long, Houfang, Shengnan Zhang, Yilun Tong, et al.. (2022). Interaction of RAGE with α-synuclein fibrils mediates inflammatory response of microglia. Cell Reports. 40(12). 111401–111401. 45 indexed citations
4.
Long, Houfang, et al.. (2022). Cellular and animal models to investigate pathogenesis of amyloid aggregation in neurodegenerative diseases. Biophysics Reports. 8(1). 14–28. 5 indexed citations
5.
Long, Houfang, et al.. (2022). Biochemical and biophysical characterization of pathological aggregation of amyloid proteins. Biophysics Reports. 8(1). 42–54. 5 indexed citations
6.
Wang, Fangru, Ting Jin, Hongyuan Li, et al.. (2022). Cannabidivarin alleviates α‐synuclein aggregation via DAF ‐16 in Caenorhabditis elegans. The FASEB Journal. 37(2). e22735–e22735. 7 indexed citations
7.
Long, Houfang, Yang Liu, Yunpeng Sun, et al.. (2021). Wild-type α-synuclein inherits the structure and exacerbated neuropathology of E46K mutant fibril strain by cross-seeding. Proceedings of the National Academy of Sciences. 118(20). 43 indexed citations
8.
Sun, Yunpeng, Houfang Long, Wencheng Xia, et al.. (2021). The hereditary mutation G51D unlocks a distinct fibril strain transmissible to wild-type α-synuclein. Nature Communications. 12(1). 6252–6252. 62 indexed citations
9.
Zhao, Kun, Yeh‐Jun Lim, Zhenying Liu, et al.. (2020). Parkinson’s disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM. Proceedings of the National Academy of Sciences. 117(33). 20305–20315. 146 indexed citations
10.
Liu, Zhenying, Shengnan Zhang, Jinge Gu, et al.. (2020). Hsp27 chaperones FUS phase separation under the modulation of stress-induced phosphorylation. Nature Structural & Molecular Biology. 27(4). 363–372. 116 indexed citations
11.
Zhao, Kun, Yaowang Li, Zhenying Liu, et al.. (2020). Parkinson’s disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure. Nature Communications. 11(1). 2643–2643. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026